granisetron transdermal system (patch), Sancuso

Pharmacy Author:
Medical and Pharmacy Editor:
Medical and Pharmacy Editor:

GENERIC NAME: granisetron transdermal system (patch)

BRAND NAME: Sancuso

DRUG CLASS AND MECHANISM: Sancuso is granisetron delivered via a transdermal patch system for the prevention of nausea and vomiting resulting from chemotherapy for cancer. Other formulations of granisetron (for example, Kytril) are administered by mouth or injection. Certain chemotherapeutic agents used for treating cancer stimulate the release of a neurotransmitter called serotonin from nerves in the brain. Neurotransmitters are chemicals that nerves use to communicate with one another. Released serotonin binds to other nerves in an area of the brain called the chemoreceptor trigger zone, causing nausea and vomiting. Granisetron, the active ingredient in Sancuso, prevents serotonin from binding to nerves in the chemoreceptor trigger zone thereby preventing nausea and vomiting. The FDA approved Sancuso in September 2008.

GENERIC AVAILABLE: No

PRESCRIPTION: Yes

PREPARATIONS: Transdermal patch delivering 3.1 mg/24 h

STORAGE: Sancuso should be store in the original package at 15 C and 30 C (59 F and 86 F).

PRESCRIBED FOR: Granisetron patches are used for prevention of nausea and vomiting in patients receiving five consecutive days of chemotherapy that is associated with nausea and vomiting.

Medically Reviewed by a Doctor on 8/1/2014



Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.


Back to Medications Index